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Abstract
Purpose To determine the effect of changing illuminance on
visual and stereo acuity.
Methods Twenty-eight subjects aged 21 to 60 years were
assessed. Monocular visual acuity (ETDRS) of emmetropic
subjects was assessed under 15 different illuminance levels
(50–8000 lux), provided by a computer controlled halogen
lighting rig. Three levels of myopia (−0.50DS, −1.00DS &
1.50DS) were induced in each subject using lenses and visual
acuity (VA) was retested under the same illuminance condi-
tions. Stereoacuity (TNO) was assessed under the same levels
of illuminance.
Results A one log unit change in illuminance level (lx) results
in a significant change of 0.060 LogMAR (p<0.001), an ef-
fect that is exacerbated in the presence of induced myopic
refractive error (p<0.001). Stereoacuity scores demonstrate
statistically significant overall differences between illumi-
nance levels (p<0.001).
Conclusions The findings of this study demonstrate that
changes in illuminance have a statistically significant effect
on VA that may contribute to test/retest variability. Increases
in illuminance from 50 to 500 lx resulted in an improved VA
score of 0.12 LogMAR. Differences like these have
significant clinical implications, such as false negatives during
vision screening and non-detection of VA deterioration, as the
full magnitude of any change may be hidden. In research
where VA is a primary outcome measure, differences of 0.12
LogMAR or even less could affect the statistical significance
and conclusions of a study. It is recommended that VA assess-
ment always be performed between 400 lx and 600 lx, as this
limits any effect of illuminance change to 0.012 LogMAR.
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Introduction
The original LogMAR letter chart (Bailey-Lovie) was intro-
duced in 1976 as an alternative to the ‘unsatisfactory’ Snellen
chart [1], and has undergone one major revision to become the
gold standard test for use in the clinic and for research
(ETDRS) [2]. It is easier to resolve two points when contrast
is increased, which for black objects on a white background, is
easily achieved by increasing the luminance of the white back-
ground. Due to this, the ETDRS study protocol stated that an
illumination level between 807 lux (lx) and 1345 lx [3] should
be used during testing. To meet this requirement, self-
illuminated charts were developed to control the amount of
light falling on the chart. However, whilst these illuminated
charts maintain the required chart illuminance in a dark room,
any external illumination will influence the amount of light
falling on the chart, and thus vary the level of visual acuity
(VA) measured [4]. Many VA test charts are not illuminated,
such as the hand-held books used in paediatric investigation or
in the community clinics. Variations in the level of natural
light, the overhead lighting and the cleanliness of the chart
could all contribute to a change in apparent luminance. The
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recognition of disparity also benefits from good contrast [5]
and so could be subject to variations in illuminance levels,
especially as most stereo tests are not illuminated and are
reliant on room illumination alone.
Previous studies differ in their findings. Variations in retro
illumination are reported to not change the VA score achieved
until the luminance of the chart falls to 1 cd/m2 or below [6, 7];
however, room (direct) illumination has been demonstrated to
affect the outcome score of a VA test even when using an
illuminated chart. Varying room illumination between a high
(250/300 lx and 1300 lx) and low (2.5 lx and 90 lx) level
resulted in significant reductions in the VA of three to four
letters [4, 8]. Similarly, a decrease of VA has been demonstrat-
ed using neutral density filters to reduce apparent luminance
[9]. Whilst the reduction of background illumination has an
effect on emmetropic subjects, changes in illumination are
more marked in patients with refractive errors, including rel-
atively small errors [4, 8, 9]. Some studies have found that VA
is similarly affected by refractive blur across all luminance
levels tests [9], whereas others have found the size of effect
of blur varies depends on luminance level [10].
Table 1 shows lighting levels recommended by ‘British
Standards’ for various areas and tasks, with a recommended
maintained illuminance level for vision testing rooms of
500 lx [12]. Assuming clinics and schools in the UK meet
the recommended levels, there could feasibly be a 200 lx to
400 lx difference in the illuminance between the clinic and
school environment. Even within hospitals, the variation be-
tween a room used for eye examination/surgery and a room
designed for vision testing could be at least 500 lx.
The aim of this study was to investigate the effect of illu-
mination change on visual and stereo acuity by assessing acu-
ity under a wide and relevant range of well controlled illumi-
nance levels. This improves on previous studies where a lim-
ited number of illuminance levels were used (e.g. room lights
on or off), allows the construction of a robust statistical model
and provides novel data on the effect of illuminance on
stereoacuity.
The level of illumination (the amount of light that falls on
the chart) in this study is controlled, and referred to, rather
than chart luminance (the amount of light emitted by the
chart), as used in most other studies in this area. In clinical,
screening, or general research situations, there is very little
control over how much light is emitted from a chart surface;
however, factors such as ensuring all overhead lighting works,
or not presenting the test in bright sunlight, can easily be
considered and adjusted.
Materials and methods
Ethical approval was gained from the University of Liverpool
Ethics Sub-committee, and the experiments were performed in
accordance with the ethical standards laid down in the 1964
Declaration of Helsinki. Subjects aged 18–60 years were re-
cruited fromwithin the University of Liverpool and all subjects
provided informed, signed consent prior to entry into the study.
Subjects were screened and excluded if corrected VA in the
better eye was worse than 0.300 LogMAR, or if cataract,
aphakia, anomalies of pupils or accommodation or any retinal
disorder (determined by subject history) were present.
Subjects were excluded from stereopsis testing if a manifest
strabismus determined by cover testing was present.
Testing was carried out in a 3.5 m by 4 m light proofed
room. All three 3-m variations of the ETDRS chart
(PrecisionVisionTM) were used for VA assessment, and VA
scored using a modified per letter scoring method [13], where
all mistakes prior to the penultimate line were ignored. The
charts were backed with high quality optical white paper (as
the retro-illuminated cabinet was not used) to simulate non-
illuminated VA tests. The TNO stereotest (Richmond
Products) was used to assess stereoacuity (SA) using the
Table 1 British standards recommended minimum illuminance levels [11]
Ref. No. (from British standards document) Type of area or task Maintained illuminance (lx)
5.1.1 Corridors 100
5.2.4 Washroom/Toilets 200
5.17.6 Quality control 1000
5.15.3 Watch making 1500
5.26.2 Office – writing, typing, reading, data processing 500
5.36.1 Classrooms/Tutorial rooms 300
5.36.3 Lecture halls 500
5.36.24 Sports halls 300
Healthcare premises – eye examination rooms
5.41.1 General lighting 500
5.41.2 Examination of the outer eye/Operating theatre 1000
5.41.3 Reading and colour vision tests with vision charts 500
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standard protocol. A 2200-Watt computer controlled lighting
system was positioned to provide diffuse lighting of the room
and test area. An illuminance meter (Precision Gold TM) was
positioned on the VA chart and 15 illumination levels were
programmed between 50 lx and 8000 lx. The illuminance of
‘daylight’ is 10,000 lx, whilst direct sunlight can be up to 130,
000 lx [11]. As windows only transmit a reduced proportion of
light [14], 8,000 lx was the maximum level of illuminance
used in the study.
Current literature suggests that those with refractive errors
could be subject to a larger change in VA score related to
changing illuminance than those without [4, 8, 9]; therefore,
any amount of underlying refractive error, as determined by
photorefraction (PlusOptiX S04), was fully corrected prior to
experimentation (spherical and cylindrical). In addition to
emmetropia (Rx State 0), we induced in each subject the
following levels of myopic error: 0.50DS (Rx State 1),
1.00DS (Rx State 2) and 1.50DS (Rx State 3).
VA testing was repeated until each eye had been tested
in each of the refractive states during one session of up to
an hour in duration. Illuminance level was randomised,
with the VA chart changed between each alteration in
illuminance level. The eye tested and refractive state used
was block randomised (one eye and one refractive state
was used until all illuminance levels were tested). All
testing was performed by one of the authors (LT), to en-
sure consistent encouragement and scoring.
Statistical methods
To determine the sample size required for the present study,
Altman’s nomogram was used [15] with power 0.8 and a
clinically relevant difference 0.1 LogMAR. Since the
ETDRS chart provides test/retest variability (TRV) for chil-
dren and adults ranging from 0.01 to 0.18 LogMAR [2,
16–21], we used the middle of these values to arrive at a
sample size of 21 subjects.
We studied the changes in visual acuity at each illuminance
and refractive state via a linear mixed-effects model [22]. To
account for the possible correlation of measurements coming
from same subject and from the same eye, we assume random
effects of a subject and eye. The model derived is as follows:
logMarijkl ¼ β0 þ β01 þ wið Þlog10 Illumkð Þ þ β021RS1 þ ui
þ β031log10 Illumkð Þ*RSl þ ei j
where i is index for individuals, j is index for eyes (1 for left
and 2 for right eye), k is index for the levels of illuminance, l is
index for the levels of refractive state (0–3), Illumk is k -th
level of the covariate illuminance and RSl are the four levels
of the factor refractive state.
The term wi and ui are subject specific random effects.
They are assumed to have Gaussian distribution with non-
zero mean and unknown correlation that is to be estimated
from the data via the maximum likelihood principle.
Furthermore, the term eij is a zero-mean Gaussian residual
term (within-eye error term) of any unexplained changes in
LogMAR due to specific characteristics of the jth eye on ith
subject. To find the best descriptive model for VA, we used
model selection criteria (Akaike information criterion and
likelihood-ratio test). The standard diagnostic of residuals of
the final model was then performed. This model was then used
to calculated 95 % family-wise confidence intervals.
The TNO Stereoacuity test allows assessment at 480, 240,
120, 60, 30 and 15 seconds of arc only. Due to this, data are
not normally distributed; hence, the Friedman non-parametric
test was used to detect differences in stereoacuity at different
levels of illuminance.
Results
A total of 28 subjects were recruited with mean (SD) age 32
(11) years; no subject had VAworse than 0.300 LogMAR and
none had manifest strabismus. VA levels are shown in Table 2
for each level of illuminance tested, with the profiles of three
individual subjects shown in Fig. 1.
Is there a relationship between illuminance and VA score?
In order to identify a statistical model, the VA profiles of each
subject were plotted, with three typical profiles shown in
Fig. 2. A degree of improved VA across increasing
Table 2 Mean LogMARVA for each illuminance level tested
Illuminance level (Lx) VA right eye
Mean (SD)
VA left eye
Mean (SD)
50 0.32 (0.31) 0.30 (0.27)
75 0.29 (0.30) 0.29 (0.27)
100 0.30 (0.32) 0.28 (0.26)
150 0.27 (0.30) 0.23 (0.27)
200 0.24 (0.28) 0.22 (0.30)
300 0.22 (0.31) 0.21 (0.28)
500 0.22 (0.28) 0.13 (0.25)
750 0.16 (0.27) 0.17 (0.25)
1000 0.18 (0.31) 0.13 (0.23)
1500 0.16 (0.27) 0.12 (0.21)
2000 0.14 (0.24) 0.08 (0.20)
3000 0.13 (0.26) 0.06 (0.21)
4000 0.11 (0.23) 0.10 (0.21)
6000 0.08 (0.21) 0.07 (0.21)
8000 0.06 (0.24) 0.04 (0.17)
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illuminance levels is shown, with an indication that this may
depend on refractive level.
The effect of illuminance on VA score is significant
(p<0.001), with a Log (illuminance) increase of one unit
resulting in an improvement of 0.06 LogMAR (Table 3). For
example, an illuminance increase from 100 lx to 1,000 lx
caused an average improvement of 0.06 LogMAR.
Analogically, the illuminance decrease from 2,000 to 200 lx
results in a poorer VA score of, on average, 0.06 LogMAR.
Is any effect of illuminance change exacerbated
by the presence of myopic error?
In refractive state 0, a unit increase in log-illuminance from the
reference level of 500 lx (i.e. a ten-fold increase into 5000 lx)
is associated with an average improvement of 0.06 in
LogMAR (p<0.001), see Table 3. This effect is more marked
in the presence of myopia. The effect of illuminance on
refractive states 1, 2 and 3 is significantly different to that in
refractive state 0 (p=0.035, < 0.001 and < 0.001). In refractive
state 1 (0.50DS Myopia), a tenfold increase in illuminance
causes an average improvement of 0.07 LogMAR (0.06+
0.01). In refractive states 2 and 3, the same increase in illumi-
nance results in an improvement in VA of 0.10 (0.06+0.04)
and 0.12 (0.06+0.06) LogMAR.
The effect of illuminance and refractive state on VA is
summarised in Fig. 3. This demonstrates two main findings:
all confidence intervals do not contain zero, which provides
strong evidence that all 14 illuminance levels contain VA
scores that are significantly different from those at the recom-
mended illuminance level for VA testing. Secondly, an in-
crease in refractive state from RXState 0 through to RxState
3 depicts a steeper gradient, and therefore a greater effect of
illuminance as RxState increases (p=0.04, < 0.001, < 0.001).
Do changes in illuminance affect the level of stereoacuity
achieved?
The data indicate some subtle improvement of stereoacuity
over increasing level of illuminance (see means, Table 4).
Fig. 1 Mean VA change from the
baseline 500 lx. The bars are 95%
family-wise confidence intervals
Fig. 2 Changes of VA (LogMAR)
from reference VA at 500 lx (2.7
in logarithmic scale) in three
typical subjects. The data indicate
possible effects of Rx state,
illuminance, interaction and
subject specific baseline (500 lx)
values
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Changes in stereoacuity score, from score at 500 lx (Table 4)
were statistically significant (χ2 (14)=68.21, p<0.001). The
stereoacuity at 50 lx is worse than at 500 lx (p= 0.027,
Wilcoxon test), and stereoacuity at 8,000 lx is slightly better
than at 500 lx, though not significant (p=0.088). Multiple
post hoc comparisons (Wilcoxons signed rank test) were not
performed as the study was not powered for this analysis.
Discussion
The test, re-test variability of ETDRS LogMAR charts, typical-
ly ranges from 0.01 to 0.18 LogMAR [2, 16–21], a contributing
factor to which could be variances in illuminance, demonstrat-
ed by the significant relationship between task illuminance and
score achieved during VA assessment. These data agree with
findings demonstrated previously [4, 8, 9], with some studies
relating a log unit change in illuminance to a smaller change of
0.03 LogMAR [23] and others to a larger change of 0.13
LogMAR [24]. The main finding of a change in LogMAR
acuity of 0.06 per log unit change in illuminance, is similar to
that found in previous papers. For example, Sheedy et al. found
that a doubling of the level of luminance (0.3 log units), results
in a “1 letter” change in acuity (0.02 LogMar) [6]. A one-unit
change would be the equivalent of between three and four
letters or a 0.067 LogMar change, as found in the current study..
The effect of variation in illuminance as described by the
linear model, may not directly relate to a ‘per letter’ score. A
0.02 LogMAR difference specified by the model relates to a
continuous measurement of the minimal angle of resolution,
and not the ‘control mechanism’ (one of five letters on a line)
usually considered a 0.02 difference. The findings of this
study suggest that even a small change in illuminance may
have a large impact on VA, as the resolution difficulty of each
line is changed by a variation of illuminance. At threshold
form identification resolution, a slight decrease in illuminance
could prevent the identification of the optotypes.
Stereoacuity scores, whilst demonstrating overall differ-
ences with illuminance level change, show nil or very small
differences on an individual basis, in line with previous find-
ings [25, 26], suggesting binocular changes in illuminance do
not affect stereoacuity score. The overall differences demon-
strated would not provide enough of an improvement, to be
detectable using the TNO stereoacuity test due to the large
intervals between testable levels. When illuminance levels
vary between each eye however, stereoacuity scores have
been demonstrated to worsen [27]. The extinction of the red
and green TNO stimuli may be disrupted by increased illumi-
nance, as any error in the colour match between the print and
Table 3 Effect of illuminance
and refractive state on visual
acuity showing mean change in
LogMAR score from reference
level (500 lx). β values are
provided for reference with the
model provide earlier
Coefficient Standard error p value
Intercept β0 0.086 0.023 < 0.001
Log (illuminance) β01 −0.060 0.006 < 0.001
Refractive state β02l 0 Reference
l = 1 0.072 0.018 < 0.001
l = 2 0.310 0.026 < 0.001
l = 3 0.641 0.035 < 0.001
Log(Illum)*Refractive state β03l 0 Reference
l = 1 −0.010 0.005 0.040
l = 2 −0.037 0.005 < 0.001
l = 3 −0.0643 0.0048 < 0.001
Fig. 3 Mean VA change from the
baseline 500 lx. The bars are 95%
family-wise confidence intervals
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the glasses will be highlighted. Dependent on the spectra of
the illuminant, each colour may be presented at a slightly
different illuminance to each retina, through greater absor-
bance of specific wavelengths of light. This could be a reason
for the exceptional stereoacuity score at 750 lx; at this amount
of illumination, one colour could have been significantly
brighter than the other.
This study has demonstrated that changes in illuminance
levels have an increased effect in the presence ofmyopia; smaller
changes in illuminance result in larger changes in VA. It is plau-
sible that the improvement in VA at higher illuminance levels in
the presence of myopic blur could be attributable to a decrease in
the blur formed on the retina by a decrease in pupil size. This
could have been controlled through the use of cycloplegia and an
artificial pupil; however, we wished to find out the effect of
changing illuminance on VA under conditions where VA is most
likely to be assessed. In other words, subjects who are undergo-
ing vision screening or VA assessment to monitor conditions are
not going to have their pupil size controlled, and will be affected
by room illumination, as in this study. Evidence suggests that for
those with low vision, an increase in illuminance is highly ben-
eficial in improving VA [23, 28], ergo higher levels of illumi-
nance can act to mask the presence of disease. If reduced VA is
masked by higher than standard illuminance during vision
screening, a false negative referral could occur.
In research situations, where trials take place not only in
different rooms, but in different hospitals, the possibility of
large differences in test chart illumination is greater. If a sub-
ject moves between rooms/centres, they could be subject to a
large change in illuminance and therefore VA level. A recent
study has explicit in its protocol that treatment is to be repeat-
ed if patient VA does not improve by five letters [29].
If pre-treatment VAwas tested on a bright sunny day, and post-
treatment was assessed on a dull day, the full magnitude of
improvement may be masked. The data from this study shows
that illuminance changes can easily cause a one letter VA
change in emmetropes; even falling one letter short of the ‘five
letter improvement’ would result in re-treatment.
Testing took place over a prolonged period, and so
fatigue may have reduced the accuracy of measurement
during the last part of testing. Counter to this, a learning
effect may have benefitted later testing. Either of these
factors should have been controlled for by the randomisation
of illumiance levels and alternation of charts used.
Hypermetropic errors were not induced, as the subjects could
accommodate to overcome the additional convex lens and use
of cycloplegia would affect pupil responses. Hypermetropic
subjects with more than +1.50DS of hypermetropia could
have been recruited, with partial correction given to simulate
different levels. The use of accommodation could not have
been eliminated or easily monitored, thereby not providing a
consistent level of refractive error, or negating it entirely.
Specifically recruiting presbyopes for this purpose would
have biased the sample.
We suggest that protocols for research involving VA testing,
especially as a primary outcome, should consider and specify a
tolerable range of illuminance to reduce test/retest variability as
a result of illuminance difference that may otherwise introduce
error in determining outcomes. Clinical environments should
aim tomaintain a consistent level of illumination inter and intra
VA testing areas. When assessing and screening VA in the
community, illuminance should be measured using an illumi-
nance meter (which is relatively inexpensive) to ensure consis-
tent standards. As demonstrated by these data, high levels of
illuminance can reduce the detrimental effect of a VA, reducing
disease by over 0.1 LogMAR. Maintaining illuminance levels
of between 400 lx and 600 lx should limit any deviation of VA
score, to a maximum of 0.012 LogMAR.
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Table 4 Effect of illuminance change on stereoacuity
Illuminance level (lx) Stereoacuity (arc sec) Mean (SD)
50 121 (122)
75 103 (100)
100 123 (121)
150 122 (124)
200 102 (96)
300 98 (93)
500 101 (96)
750 118 (122)
1000 100 (97)
1500 98 (97)
2000 95 (93)
3000 86 (89)
4000 86 (89)
6000 84 (89)
8000 88 (89)
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